Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 47NET 27Gastrointestinal 26Thoracic 8Sarcoma 6Head & Neck 6CNS 6Dermatologic 5Genitourinary 3Breast 3Other solid neoplasm 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Ovarian Neoplasms 2565Uterine Cervical Neoplasms 1684Endometrial Neoplasms 1008Fallopian Tube Neoplasms 729Carcinoma, Ovarian Epithelial 680Breast Neoplasms 673Neoplasms 436Carcinoma, Non-Small-Cell Lung 377Colorectal Neoplasms 370Pancreatic Neoplasms 302Stomach Neoplasms 301Uterine Cervical Dysplasia 273Prostatic Neoplasms 261Lung Neoplasms 250Melanoma 247Neoplasm Metastasis 214Peritoneal Neoplasms 197Carcinoma, Renal Cell 192Sarcoma 189Head and Neck Neoplasms 188Urinary Bladder Neoplasms 187Esophageal Neoplasms 186Recurrence 184Triple Negative Breast Neoplasms 179Uterine Neoplasms 176Vulvar Neoplasms 173Squamous Cell Carcinoma of Head and Neck 166Colonic Neoplasms 162Papillomavirus Infections 152Small Cell Lung Carcinoma 126

Interventions

sapanisertib 1aflibercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenoma, Islet Cell × Gynecologic × Clear all
NCT02159989 2025-10-20

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Completed
83 enrolled 21 charts
GastrointestinalGynecologic

Fibrolamellar hepatocellular carcinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡